Tiago Fauth

Stock Analyst at Raymond James

(4.38)
# 1,312
Out of 5,134 analysts
313
Total ratings
47.5%
Success rate
9.5%
Average return

Stocks Rated by Tiago Fauth

Tonix Pharmaceuticals Holding
Nov 9, 2026
Reiterated: Buy
Price Target: $26 → $14
Current: $3.01
Upside: +365.12%
Benitec Biopharma
Oct 23, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $9.04
Upside: +54.87%
Camp4 Therapeutics
Oct 23, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $3.80
Upside: +163.16%
Insmed
Oct 20, 2026
Reiterated: Buy
Price Target: $185 → $173
Current: $121.16
Upside: +42.79%
Ionis Pharmaceuticals
Oct 20, 2026
Reiterated: Buy
Price Target: $84 → $79
Current: $29.06
Upside: +171.85%
Milestone Pharmaceuticals
Oct 20, 2026
Reiterated: Buy
Price Target: $6 → $5
Current: $0.52
Upside: +861.54%
PTC Therapeutics
Oct 20, 2026
Reiterated: Buy
Price Target: $95 → $106
Current: $63.49
Upside: +66.96%
Rapport Therapeutics
Oct 20, 2026
Reiterated: Buy
Price Target: $86
Current: $26.15
Upside: +228.87%
United Therapeutics
Oct 20, 2026
Reiterated: Buy
Price Target: $700 → $717
Current: $591.17
Upside: +21.28%
IRulya Therapeutics
Oct 9, 2026
Initiated Coverage: Buy
Price Target: $72
Current: $39.80
Upside: +80.90%
Initiated Coverage: Buy
Price Target: $60
Current: $30.28
Upside: +98.15%
Initiated Coverage: Buy
Price Target: $46
Current: $19.98
Upside: +130.23%
Reiterated: Buy
Price Target: $945
Current: $328.13
Upside: +188.00%
Initiated Coverage: Buy
Price Target: $6
Current: $1.77
Upside: +238.98%
Initiated Coverage: Buy
Price Target: $46
Current: $7.25
Upside: +534.48%
Reiterated: Buy
Price Target: $76 → $98
Current: $78.30
Upside: +25.16%
Reiterated: Buy
Price Target: $227 → $239
Current: $241.55
Upside: -1.06%
Reiterated: Buy
Price Target: $26 → $20
Current: $10.30
Upside: +94.17%
Reiterated: Buy
Price Target: $10 → $7
Current: $4.13
Upside: +69.49%
Reiterated: Buy
Price Target: $21 → $18
Current: $3.13
Upside: n/a
Reiterated: Buy
Price Target: $25 → $31
Current: $57.41
Upside: n/a
Reiterated: Buy
Price Target: $101
Current: $21.14
Upside: n/a
Reiterated: Hold
Price Target: $333 → $395
Current: $165.04
Upside: n/a
Reiterated: Buy
Price Target: $88 → $65
Current: $16.08
Upside: n/a
Reiterated: Buy
Price Target: $8 → $7
Current: $4.64
Upside: n/a
Reiterated: Buy
Price Target: $91
Current: $80.00
Upside: n/a
Reiterated: Hold
Price Target: $4 → $3
Current: $0.697
Upside: n/a
Initiated Coverage: Hold
Price Target: $16
Current: $9.85
Upside: n/a
Downgraded: Hold
Price Target: $35 → $70
Current: $16.14
Upside: n/a
Initiated Coverage: Hold
Price Target: $89
Current: $275.39
Upside: n/a
Initiated Coverage: Buy
Price Target: $120
Current: $57.23
Upside: n/a
Initiated Coverage: Buy
Price Target: $51
Current: $30.87
Upside: n/a
Reiterated: Buy
Price Target: $4
Current: $43.31
Upside: n/a
Reiterated: Buy
Price Target: $29 → $26
Current: $7.77
Upside: n/a
Reiterated: Buy
Price Target: $34 → $28
Current: $11.49
Upside: n/a
Reiterated: Sell
Price Target: $2
Current: $1.17
Upside: n/a
Reiterated: Buy
Price Target: $38 → $34
Current: $1.04
Upside: n/a
Reiterated: Buy
Price Target: $7 → $6
Current: $21.60
Upside: n/a
Initiated Coverage: Buy
Price Target: $13
Current: $4.91
Upside: n/a
Downgraded: Hold
Price Target: $33 → $13
Current: $2.17
Upside: n/a
Reiterated: Buy
Price Target: $19 → $14
Current: $1.58
Upside: n/a
Reiterated: Buy
Price Target: $28 → $14
Current: $8.45
Upside: n/a
Reiterated: Hold
Price Target: $340 → $319
Current: $960.04
Upside: n/a
Downgraded: Sell
Price Target: $12 → $7
Current: $34.18
Upside: n/a
Reiterated: Buy
Price Target: $265 → $259
Current: $465.67
Upside: n/a